CID 11335389

Normacusine b

Structural Information

Molecular Formula
C19H22N2O
SMILES
C/C=C\1/CN2[C@H]3C[C@@H]1[C@H]([C@@H]2CC4=C3NC5=CC=CC=C45)CO
InChI
InChI=1S/C19H22N2O/c1-2-11-9-21-17-8-14-12-5-3-4-6-16(12)20-19(14)18(21)7-13(11)15(17)10-22/h2-6,13,15,17-18,20,22H,7-10H2,1H3/b11-2-/t13-,15+,17-,18-/m0/s1
InChIKey
VXTDUGOBAOLMED-VICVVEARSA-N
Compound name
[(1S,12S,13R,14R,15E)-15-ethylidene-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraen-13-yl]methanol
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

294.17322 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 295.18050 164.3
[M+Na]+ 317.16244 169.8
[M-H]- 293.16594 160.1
[M+NH4]+ 312.20704 184.0
[M+K]+ 333.13638 162.0
[M+H-H2O]+ 277.17048 156.1
[M+HCOO]- 339.17142 168.9
[M+CH3COO]- 353.18707 171.9
[M+Na-2H]- 315.14789 170.5
[M]+ 294.17267 163.4
[M]- 294.17377 163.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.